DarioHealth Corp. has announced amendments to its Series C, C-1, and C-2 Preferred Stock bylaws. The changes extend the mandatory conversion period from 15 to 24 months from the original issue date. Additionally, a 15% dividend in Common Stock will be issued for each full quarter anniversary of holding the preferred stock following the amendments. No additional securities were issued or sold as a result of these changes.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DarioHealth Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-25-051292), on May 21, 2025, and is solely responsible for the information contained therein.